News

Construction of a New Industrial Facility in Gannat

Laboratoire Unither Coutances inaugurates its new premises and production facilities

Official launch of the CURECALL solution to ophthalmologists in France!

New in corneal transplant rejection: the ANSM issues an authorisation for the first industrial eye drop based on ciclosporin 2%.

UNITHER invests 68 million euros in the innovative project: Euroject®

Press Release – Acquisition of the Carragelose Portfolio by Unither Pharmaceuticals

BIOPHTA raises 6.5 million Euros Seed Funding to transition its New Standard of Care for Eye Diseases to the Clinical stage

Manufacturing of registration batches of PXT3003 in single unit doses

Nanjing’s R&D cell inauguration

Laboratoire Kôl Olisens® eye drops, manufactured by Unither Pharmaceuticals

Foundation stone laid for Laboratoire Unither Amiens new building

Unither Pharmaceuticals has completed the purchase of the Novartis site located at Butantã, in São Paulo, Brazil.